Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience.

Espírito Santo, Vera

Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. [electronic resource] - Journal of neuro-oncology Apr 2020 - 459-463 p. digital

Publication Type: Clinical Trial; Journal Article

1573-7373

10.1007/s11060-020-03443-6 doi


Adolescent
Adult
Benzimidazoles--therapeutic use
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Male
Neurofibroma, Plexiform--drug therapy
Neurofibromatosis 1--drug therapy
Prognosis
Stroke Volume
Young Adult